Chapters

Transcript

Video

Multiple Myeloma Research: Risks, Benefits of Stem Cell Transplant

Dana-Farber research into autologous stem cell transplant for patients with multiple myeloma: study led by Dr. Paul G. Richardson, MD, found patients had dramatically increased progression-free survival, but were just as likely to be alive more than 6 years later if they chose to reserve their transplant until later.


Published

August 11, 2022

Created by

Dana-Farber

Related Presenters